Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNOVA: Low-dose Naltrexone for Fibromyalgia
NCT04739995Phase 4Active, not recruiting
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Jun 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in fibromyalgia (FM), sponsored by Fundació Sant Joan de Déu. Started Jun 2022; status: active, not recruiting.
02
Drugs
naltrexone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT04739995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739995.